Method of determining the virus inactivation capacity of an inac

Details Method of determining the virus inactivation capacity of an inac Method of determining the virus inactivation capacity of an inac

1994-06-10

1997-03-25

Wityshyn, Michael G.

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

Inactivation or attenuation; producing viral subunits

435 4, 435 5, C12N 704, C12Q 100, C12Q 170

Patent

active

056144059

ABSTRACT:
This invention is directed to a method of evaluating viral reduction capability of a viral inactivation step in a viral inactivation procedure. The method requires spiking a biological product with a virus more than once during the viral inactivation step so that a virus reduction factor can be calculated.

REFERENCES:
patent: 4160025 (1979-07-01), Eibl et al.
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4379085 (1983-04-01), Williams
patent: 4404187 (1983-09-01), Schwinn et al.
patent: 4405603 (1983-09-01), Schwinn et al.
patent: 4480029 (1984-10-01), Dolana
patent: 4640834 (1987-02-01), Eibl et al.
patent: 4814435 (1989-03-01), Schwarz et al.
patent: 4904641 (1990-02-01), Eibl et al.
patent: 4909251 (1990-03-01), Seelich
patent: 5118794 (1992-06-01), Grangeorge et al.
patent: 5143838 (1992-09-01), Kraus et al.
patent: 5186945 (1993-02-01), Shanbrom
patent: 5498520 (1996-03-01), Chapman
H. Suomela et al. "Preparation and Properties of a Therapeutic Factor IX Concentrate", 1977, Vox Sanguinis, Journal of Blood Transfusion, Immunohaemotology and Immunopathology, vol. 33, pp. 37-50.
Ralsh Clemens et al., "Wie Virussicher Sind Blut Und Plasmaderivate?," Z. Allg. Med. 65, 429-433 (1989) pp. 429-433.
Commission of the European Communities, "Ad Hoc Working Party On Biotechnology/Pharmacy" 111/8115/89-EN Final, pp. 1-15.
D.B. Rubinstein, M.D., "Inability Of Solvent-Deterent (S-D) Treated Factor VIII Concentrate To Inactivate Parvoviruses And Non-Lipid Enveloped Non-A, Non-B Hepatitis Virus In Factor VIII Concentrate: Advantages To Using Sterilizing 100 C Dry Heat Treatment", American Journal of Hematology 35:142, 1990.
A.M. Prince et al., "The Development Of Virus-Free Labile Blood Derivatives". Eur. J. Epidemiol., Jun. 1987, pp. 103-118 vol. 3, #2.
Chemical Abstracts, vol. 111, Nov. 27, 1989, No. 22, 201439j.
Chemical Abstracts, vol. 114, Feb. 4, 1991, No. 5, 39082a.
Rozenberg et al., XII International Congress on Blood Transfusion Abstracts, Aug. 17-23, 1969, Moscow, pp. 473-475.
Chemical Abstracts, Pharmaceuticals, vol. 84, No. 16, Apr. 19, 1976, US Abstract No. 111640n p. 405.
Brummelhuis, "Preparation of the Prothrombin Complex", Methods of Plasma Protein Fractionation, pp. 117-125 (1980).
Mannucci, "Outbreak of Hepatitis A Among Italian Patients with Haemophila", The Lancet, vol. 339, p. 819 (Mar. 28, 1992).
Pape et al., "Standardization of an in vitro Red Blood Cell Test for Evaluating the Acute Cytotoxic Potential of Tensides", Arzneim.-Forsch./Drug Res. 40., pp. 498-502 (1990).
Vogelaar et al., "Contributions to the Optimal Use of Human Blood", Vox Sanguinis, vol. 26, (1974)pp. 118-127.
Mannucci et al., "Low Risk of Viral Infection After Administration of Vapor-Heated Factor VIII Concentrate", Transfusion, vol. 32, pp. 134-138 (1992).
Muller, "New Ion Exchangers for the Chromatography of Biopolymers", Journal of Chromatography, 510, pp. 133-140 (1990).
Hellmut Hartert, "Thrombosis and Bleeding Disorders", Academic Press, New York, 1971, pp. 70-76.
T. Seelich et al., "Fibrinogen, Fibrin and Fibrin Glue, Side Effects of Therapy with Clotting Factor Concentrates", F.K. Schattauer Verlag, Stuttgart, New York, 1980, pp. 199-208.

Affiliated with

Also associated with

Rating

Method of determining the virus inactivation capacity of an inac does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of determining the virus inactivation capacity of an inac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining the virus inactivation capacity of an inac will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2202526